Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
ArticleAbstract: The aim was to determine the effects of dulaglutide, a synthetic once-weekly, injectable human glucaPalabras claves:antidiabetic drug, Cardiovascular disease, Clinical trial, diabetes complications, GLP-1 receptor agonistAutores:Atisso C.M., Avezum A.J., Basile J.N., Cardona-Munoz E.G., Chung N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., DIaz R., Franek E., Gerstein H.C., Hâncu N., Hanefeld M., Holt S., Jansky P., Keltai M., Lakshmanan M., Lanas F., Leiter L.A., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Xavier D.Fuentes:scopusVitamin D supplementation and adverse skeletal and non-skeletal outcomes in individuals at increased cardiovascular risk: Results from the International Polycap Study (TIPS)-3 randomized controlled trial
ArticleAbstract: Background and aims: Vitamin D has mostly been tested in Western populations. We examined the effectPalabras claves:Cáncer, Cardiovascular disease, death, Falls, fractures, vitamin DAutores:Bosch J., Christou C., Dagenais G.R., Dans A.M., Gamra H., Gao P., Joseph P.G., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Teo K., Tyrwhitt J., Xavier D., Yusoff K., Yusuf S.Fuentes:googlescopus